Correlation Between CREDITACCESS GRAMEEN and Mangalam Drugs

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both CREDITACCESS GRAMEEN and Mangalam Drugs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CREDITACCESS GRAMEEN and Mangalam Drugs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CREDITACCESS GRAMEEN LIMITED and Mangalam Drugs And, you can compare the effects of market volatilities on CREDITACCESS GRAMEEN and Mangalam Drugs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CREDITACCESS GRAMEEN with a short position of Mangalam Drugs. Check out your portfolio center. Please also check ongoing floating volatility patterns of CREDITACCESS GRAMEEN and Mangalam Drugs.

Diversification Opportunities for CREDITACCESS GRAMEEN and Mangalam Drugs

-0.23
  Correlation Coefficient

Very good diversification

The 3 months correlation between CREDITACCESS and Mangalam is -0.23. Overlapping area represents the amount of risk that can be diversified away by holding CREDITACCESS GRAMEEN LIMITED and Mangalam Drugs And in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mangalam Drugs And and CREDITACCESS GRAMEEN is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CREDITACCESS GRAMEEN LIMITED are associated (or correlated) with Mangalam Drugs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mangalam Drugs And has no effect on the direction of CREDITACCESS GRAMEEN i.e., CREDITACCESS GRAMEEN and Mangalam Drugs go up and down completely randomly.

Pair Corralation between CREDITACCESS GRAMEEN and Mangalam Drugs

Assuming the 90 days trading horizon CREDITACCESS GRAMEEN LIMITED is expected to generate 1.72 times more return on investment than Mangalam Drugs. However, CREDITACCESS GRAMEEN is 1.72 times more volatile than Mangalam Drugs And. It trades about 0.03 of its potential returns per unit of risk. Mangalam Drugs And is currently generating about -0.19 per unit of risk. If you would invest  90,200  in CREDITACCESS GRAMEEN LIMITED on October 30, 2024 and sell it today you would earn a total of  2,180  from holding CREDITACCESS GRAMEEN LIMITED or generate 2.42% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

CREDITACCESS GRAMEEN LIMITED  vs.  Mangalam Drugs And

 Performance 
       Timeline  
CREDITACCESS GRAMEEN 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days CREDITACCESS GRAMEEN LIMITED has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, CREDITACCESS GRAMEEN is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.
Mangalam Drugs And 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Mangalam Drugs And has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unfluctuating performance, the Stock's essential indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

CREDITACCESS GRAMEEN and Mangalam Drugs Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with CREDITACCESS GRAMEEN and Mangalam Drugs

The main advantage of trading using opposite CREDITACCESS GRAMEEN and Mangalam Drugs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CREDITACCESS GRAMEEN position performs unexpectedly, Mangalam Drugs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mangalam Drugs will offset losses from the drop in Mangalam Drugs' long position.
The idea behind CREDITACCESS GRAMEEN LIMITED and Mangalam Drugs And pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Other Complementary Tools

Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios